Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

KWIK-LAC BETA-LACTAMASE KITS

K-Number: K811442 · 1981-06-18

Decision Date1981-06-18
Product Code
DecisionSubstantially Equivalent

Device Summary

KWIK-LAC BETA-LACTAMASE KITS is the device name listed in this FDA 510(k) record. The listed applicant is Windsor Laboratories, Inc.. It received FDA 510(k) clearance on 1981-06-18 under 510(k) number K811442. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the KWIK-LAC BETA-LACTAMASE KITS?

KWIK-LAC BETA-LACTAMASE KITS is a medical device that received FDA 510(k) clearance on 1981-06-18. The listed applicant is Windsor Laboratories, Inc.. The 510(k) number is K811442.

When did KWIK-LAC BETA-LACTAMASE KITS receive FDA 510(k) clearance?

KWIK-LAC BETA-LACTAMASE KITS received FDA 510(k) clearance on 1981-06-18, under 510(k) number K811442.

Who is the listed applicant for KWIK-LAC BETA-LACTAMASE KITS?

The FDA 510(k) record lists Windsor Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Windsor Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 19 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑